InsidersTradesSigma
Track the Wuhan YZY Biopharma Co., Ltd. - B share price and the full directors' dealings record of the company, a listed issuer based in Hong Kong. Shares trade on the HK market, under the supervision of HKEX. Operating in the Health Care sector, Wuhan YZY Biopharma Co., Ltd. - B has published 8 insider filings. Market capitalisation: €740.7m. The latest transaction was filed on 1 April 2026 (Purchase). Among the most active insiders: WEN Zhicheng. Every trade is openly available.
8
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
4 ops.
Sell Volume
3Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 April 2026
Declarations8 total
5,059,039 sharesShareXHKGHKEX:DA20260331E00384
5,059,039 sharesShareXHKGHKEX:DA20260331E00383
54,262,305 sharesShareXHKGHKEX:DA20260331E00393
54,262,305 sharesShareXHKGHKEX:DA20260331E00392
54,262,305 sharesShareXHKGHKEX:DA20260331E00391
54,262,305 sharesShareXHKGHKEX:DA20260331E00390
8 of 8 declarations
About Wuhan YZY Biopharma Co., Ltd. - B
Wuhan YZY Biopharma Co., Ltd. is a company focused on the health and pharmaceutical sector. It is listed on the Hong Kong Stock Exchange (XHKG).